Insider Buying: E*TRADE and Cheesecake Factory Are Targets
IMAX and Opko Health are also stocks insiders are buying. Nearly all have been rated "underperform."
Insiders may sell shares for any number of reasons, but there is really only one reason insiders buy shares of a company: They believe the stock price will move higher and they want to profit from it. Pullbacks and sell-offs provide a perfect opportunity for investors who have faith in a company to snap up shares. Below are some stocks that have seen insider buying recently:
Cheesecake Factory (CAKE): A director purchased 25,000 shares of this restaurant operator last week. That was worth more than $820,000. The company has a market capitalization near $1.4 billion and a long-term earnings per share (or EPS) growth forecast of 14.3%. Its dividend yield is 1.4%. Shares are trading near the 52-week high, and the stock has outperformed competitor Darden Restaurants (DRI) and the S&P 500 over the past year.
E*TRADE Financial (ETFC): Chairman Frank Petrilli and one other director purchased more than more than 126,000 shares of this financial services company last week. That was worth more than $1 million. The board of this New York-based company recently ousted the CEO. The company's market cap is about $2.4 billion and its long-term EPS growth forecast is 12.2%. Short interest is less than 2% of the float. Over the past six months, the stock has underperformed rival TD Ameritrade (AMTD) as well as the broader markets.
IberiaBank (IBKC): A pair of directors from this Lafayette, Louisiana-based lender have bought up more than 22,000 shares, worth over $951,000, so far this month. The regional bank has a market cap near $1.4 billion. The company's price-to-earnings or P/E ratio is greater than the industry average and the dividend yield is about 2.9%. The share price has risen about 5% in the past two weeks, but that is still down about 6% year to date.
IMAX (IMAX): A 13(d )(3) group owner purchased over 299,000 more shares in the past week for more than $6.2 million. This owner has purchased more than a million shares since July 9. This leading entertainment technology company has a market cap of about $1.4 billion. Its long-term EPS growth forecast is a healthy 21.3%. But the share price has dropped more than 14% in the past month, and the stock has underperformed the broader markets during that time.
Opko Health (OPK): The chairman, Dr. Frost, continues to periodically buy batches of shares, as he has done since last November. He acquired more than 200,000 shares in the past week, which was worth more than $862,000. This Miami-based health care company has a market cap of near $1.2 billion. Short interest is a hefty 23% of the float. Shares have fallen more than 7% in the past month and are now down more than 12% year-to-date. Over the past six months, the stock has underperformed competitors such as Allergan (AGN).
Ruby Tuesday (RT): So far in August, two directors have bought 497,000 shares, worth about $3.2 million, in this operator of casual dining restaurants. The company appointed two new board members last week. The market cap is around $430 million. Short interest is more than 7% of the float. The share price dropped in July following a disappoint earnings report, but it has risen almost 5% in the past week. The stock has underperformed competitor Red Robin Gourmet Burgers (RRGB) over the past six months.
Editor's Note: This content was originally published on Benzinga.com by Nelson Hem.
Below, find some more great ETF and market content from Benzinga:
As Europe ETFs Rebound, Nordic Plays Flex Their Muscles
Best Buy Hires Joly New CEO
General Motors Joins Ford, Toyota in Recall Frenzy
Benzinga Pro covers this and all market news in real time. Get your free trial here.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Daily Recap Newsletter